EPA TSCA Draft Risk Assessment: Dichlorobenzenes Regulatory Impact

On August 10, 2026, the U.S. Environmental Protection Agency (EPA) issued draft risk assessments for ortho-dichlorobenzene (o-DCB) and para-dichlorobenzene (p-DCB) under the Toxic Substances Control Act (TSCA). The agency has preliminarily concluded that both substances present unreasonable risks to human health under various industrial and commercial conditions. Primary exposure concerns relate to the inhalation of vapors and dermal contact during processing and use. This regulatory update serves as a critical notification for procurement and supply chain managers to review current chemical inventories and risk management protocols.

Understanding the EPA TSCA Draft Risk Assessment for Dichlorobenzenes

The draft assessments specifically evaluate the entire life cycle of these chemicals, from industrial production and distribution to end-user applications and eventual disposal. Under the current TSCA mandate, the EPA is required to determine whether a chemical substance presents an "unreasonable risk of injury to health or the environment" without consideration of costs or other non-risk factors.

For o-dichlorobenzene (o-DCB), the EPA focus includes its role as a versatile solvent for dyes, specialized lubricants, and industrial degreasers. It is also frequently utilised as a chemical intermediate in the synthesis of organic compounds, including pesticides and pharmaceuticals. The EPA’s assessment highlights potential systemic toxicity resulting from chronic exposure, which could necessitate significant adjustments to Occupational Safety and Health Administration (OSHA) permissible exposure limits or workplace practices.

Conversely, the p-dichlorobenzene (p-DCB) assessment scrutinises its application in thermoplastic manufacturing, the production of polyphenylene sulfide (PPS) resins, specific lubricating greases, and various construction materials. p-DCB is also commonly recognised for its historical use in deodorising and moth-control products, though the current EPA focus is heavily weighted toward industrial and commercial manufacturing exposures. These preliminary findings suggest that the agency may propose future stringent workplace engineering controls, such as closed-loop systems, mandatory personal protective equipment (PPE) upgrades, or even potential restrictions on specific uses if engineering controls are deemed insufficient to reduce risk below the agency’s threshold of concern.

For those sourcing these fine chemicals for laboratory or industrial applications, this development implies a need for immediate supply chain due diligence. Relying on suppliers that provide a comprehensive Certificate of Analysis (CoA) is essential for ensuring that material grades remain consistent with evolving safety standards. We encourage stakeholders to review their current procurement specifications via our products catalog to ensure alignment with existing quality management systems and to ensure that hazardous substances are tracked with the necessary documentation to support internal auditing.

Impact on Sourcing and Procurement Strategy

Regulatory shifts of this nature often lead to increased compliance costs, narrowed supply bases, and potential limitations on availability. As the EPA moves through the 60-day public comment period—which concludes on October 9, 2026—formulators and R&D chemists should proactively assess if alternative substances exist for their specific processes.

Procurement strategies must evolve from a focus on cost and lead-time alone to a model that integrates "regulatory risk-weighted lead times." If substitution is not technically feasible for a proprietary synthesis or high-performance coating, companies must evaluate their internal handling procedures to mitigate risks identified by the EPA. This involves conducting rigorous industrial hygiene surveys, investing in superior local exhaust ventilation (LEV), and implementing stricter dermal exposure protocols, such as chemical-resistant glove permeability testing. Proper storage and handling are not just operational necessities; they are becoming central to regulatory compliance under the TSCA framework, as the EPA is increasingly looking at the downstream management of these chemicals.

Furthermore, procurement managers should consider the financial stability of their secondary suppliers. If a smaller manufacturer cannot afford the necessary compliance upgrades mandated by a final EPA rule, they may cease production of these compounds, leading to sudden market supply crunches.

Comparative Regulatory Outlook: Dichlorobenzenes vs. Other Solvents

To better contextualise the impact of these findings, it is helpful to compare the current regulatory standing of these dichlorobenzenes against other commonly managed industrial solvents.

Note: The table above reflects the status of common solvents as of August 2026 for comparative benchmarking purposes.

Compliance and Future Readiness

Maintaining a robust supply chain requires constant monitoring of regulatory dockets. At Tech Serve Solutions, we remain committed to assisting our partners in navigating complex regulatory environments by providing high-quality chemical reagents and intermediates. We understand that compliance is an iterative process. As the EPA finalises its determinations, companies will need to re-evaluate their Safety Data Sheets (SDS) and ensure that all internal training manuals reflect the updated hazard communication standards.

Whether you are scaling up production or refining your R&D processes, transparency in the supply chain remains our priority. We invite you to contact us to discuss how these impending regulatory changes might affect your specific sourcing requirements or to explore alternative chemistry solutions that may carry a lower regulatory burden.

As the industry adjusts to these EPA determinations, the focus will likely shift toward enhanced engineering controls. Procurement managers should prepare for potential changes in the market landscape, including possible fluctuations in pricing as the market accounts for the cost of enhanced compliance. By conducting gap analyses now, rather than waiting for the final rule, firms can secure their supply chains against disruption. Staying informed is the first step in maintaining supply chain resilience during these regulatory transitions.

In addition to internal handling, downstream disposal considerations are becoming increasingly important. If the EPA’s final risk management rule imposes restrictions on the disposal or release of these substances, companies that have already established "green chemistry" initiatives will be better positioned to transition to less hazardous alternatives. Our team is available to assist in reviewing technical specifications to ensure that your processes remain both compliant and competitive as the regulatory environment for chlorinated aromatics continues to evolve.